AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 101 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,214 | -43.1% | 6,616,423 | -1.0% | 0.01% | -40.0% |
| Q2 2023 | $74,129 | -29.6% | 6,684,241 | -2.6% | 0.01% | -37.5% |
| Q1 2023 | $105,369 | -29.2% | 6,864,385 | +2.3% | 0.02% | -33.3% |
| Q4 2022 | $148,835 | -99.8% | 6,707,287 | +29.8% | 0.02% | +71.4% |
| Q3 2022 | $84,412,000 | -26.3% | 5,169,023 | -34.4% | 0.01% | 0.0% |
| Q2 2022 | $114,542,000 | -22.3% | 7,883,125 | -1.3% | 0.01% | -6.7% |
| Q1 2022 | $147,493,000 | -19.7% | 7,985,535 | +3.3% | 0.02% | -11.8% |
| Q4 2021 | $183,786,000 | +5.2% | 7,731,846 | +9.0% | 0.02% | +6.2% |
| Q3 2021 | $174,643,000 | +178.6% | 7,090,650 | +179.5% | 0.02% | +166.7% |
| Q2 2021 | $62,691,000 | +63.5% | 2,537,071 | +44.3% | 0.01% | +50.0% |
| Q1 2021 | $38,336,000 | +59.0% | 1,757,735 | +86.0% | 0.00% | +100.0% |
| Q4 2020 | $24,112,000 | -10.6% | 944,838 | -1.3% | 0.00% | -33.3% |
| Q3 2020 | $26,958,000 | +0.4% | 957,651 | +0.8% | 0.00% | 0.0% |
| Q2 2020 | $26,858,000 | – | 950,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |